Energenesis Biomedical Co Ltd (6657)

Currency in TWD
29.70
-0.65(-2.14%)
Closed·
6657 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
29.5030.50
52 wk Range
28.3562.90
Key Statistics
Bid/Ask
29.70 / 29.80
Prev. Close
30.35
Open
30.5
Day's Range
29.5-30.5
52 wk Range
28.35-62.9
Volume
144.74K
Average Volume (3m)
197.49K
1-Year Change
-50.7463%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
6657 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Holds more cash than debt on its balance sheet

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Earnings

Latest Release
Aug 07, 2026
EPS / Forecast
-0.55 / --
Revenue / Forecast
2.06M / --
EPS Revisions
Last 90 days

6657 Income Statement

Compare 6657 to Peers and Sector

Metrics to compare
6657
Peers
Sector
Relationship
P/E Ratio
−8.8x−11.3x−0.3x
PEG Ratio
−4.14−0.230.00
Price/Book
3.7x4.4x2.6x
Price / LTM Sales
345.8x48.6x3.1x
Upside (Analyst Target)
-129.1%49.0%
Fair Value Upside
Unlock6.9%6.3%Unlock

Energenesis Biomedical CO.,LTD. operates in the biomedicine industry in Taiwan. It provides ENERGI-F703, which is Phase III clinical trial for use in treatment of diabetic foot ulcers; ENERGI-F701, a topical tonic for the treatment of alopecia that is in Phase II clinical trial; ENERGI-F711, a burn cream; ENERGI-F703VLU, a gel that treats venous leg ulcers; ENERGI-F703EB, a topical cream for treating wounds in hereditary epidermolysis bullosa; ENERGI-F702 to treat metabolic diseases; ENERGI-F704 for the treatment of inflammatory bowel disease; ENERGI-F708 for asthma treatment; ENERGI-F705 for Parkinson's disease control; ENERGI-F707 for the treatment of mitochondria deficiency; ENERGI-F706 to treat cachexia; ENERGI-F709, a vaccine adjuvant; and ENERGI-F710 for blood phosphate control. The company also offers scientific products, including western blot, cell culture supplement, protein isolation, protein quantification, dyes, and buffer solutions. Energenesis Biomedical CO.,LTD. was founded in 2012 and is based in Taipei, Taiwan.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
82.31K0.09%2.50M
Other Institutional Investors
9.60M10.92%291.27M
Public Companies & Retail Investors
78.23M88.99%2.37B
Total
87.91M100.00%2.67B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Ruby Bay Limited5.40%4,747,037144,073
SCI Pharmtech, Inc.2.05%1,804,05854,753

FAQ

What Is the Energenesis Biomedical (6657) Stock Price Today?

The Energenesis Biomedical stock price today is 29.70 TWD.

What Stock Exchange Does Energenesis Biomedical Trade On?

Energenesis Biomedical is listed and trades on the Taiwan Stock Exchange.

What Is the Stock Symbol for Energenesis Biomedical?

The stock symbol for Energenesis Biomedical is "6657."

What Is the Energenesis Biomedical Market Cap?

As of today, Energenesis Biomedical market cap is 2.61B TWD.

What Is Energenesis Biomedical's Earnings Per Share (TTM)?

The Energenesis Biomedical EPS (TTM) is -3.38.

When Is the Next Energenesis Biomedical Earnings Date?

Energenesis Biomedical will release its next earnings report on Nov 17, 2026.

From a Technical Analysis Perspective, Is 6657 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Energenesis Biomedical Stock Split?

Energenesis Biomedical has split 0 times.

What is the current trading status of Energenesis Biomedical (6657)?

As of Aug 18, 2026, Energenesis Biomedical (6657) is trading at a price of 29.70 TWD, with a previous close of 30.35 TWD. The stock has fluctuated within a day range of 29.50 TWD to 30.50 TWD, while its 52-week range spans from 28.35 TWD to 62.90 TWD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.